中国伤残医学
中國傷殘醫學
중국상잔의학
CHINESE JOURNAL OF TRAUMA AND DISABILITY MEDICINE
2015年
6期
103-104
,共2页
冠状动脉%替罗非班%急性心肌梗死%PCI
冠狀動脈%替囉非班%急性心肌梗死%PCI
관상동맥%체라비반%급성심기경사%PCI
coronary artery%tirofiban%acute myocardial infarction%PCI
目的::探讨冠状动脉内应用替罗非班在急性心肌梗死急诊经皮冠状动脉介入治疗( Percutaneous Coronary Interven-tion,PCI)中的临床效果。方法:收集2012年11月~2014年5月于本院治疗的急性心肌梗死的75例患者为研究对象,将其随机分为观察组39例和对照组36例,观察组予PCI后冠状动脉内应用替罗非班治疗,对照组予PCI后静脉内应用替罗非班治疗,然后对2组患者术后心肌再灌注指标、术后1周心功能指标、术后1个月内心脏不良事件进行统计及比较。结果:对比2组术后心肌再灌注指标、心脏不良事件,均P<0.05,存在统计学差异,术后1周心功能指标P>0.05,无统计学意义。结论:冠状动脉内应用替罗非班在急性心肌梗死急诊PCI中的临床效果,明显优于静脉内应用替罗非班,建议在临床上推广应用。
目的::探討冠狀動脈內應用替囉非班在急性心肌梗死急診經皮冠狀動脈介入治療( Percutaneous Coronary Interven-tion,PCI)中的臨床效果。方法:收集2012年11月~2014年5月于本院治療的急性心肌梗死的75例患者為研究對象,將其隨機分為觀察組39例和對照組36例,觀察組予PCI後冠狀動脈內應用替囉非班治療,對照組予PCI後靜脈內應用替囉非班治療,然後對2組患者術後心肌再灌註指標、術後1週心功能指標、術後1箇月內心髒不良事件進行統計及比較。結果:對比2組術後心肌再灌註指標、心髒不良事件,均P<0.05,存在統計學差異,術後1週心功能指標P>0.05,無統計學意義。結論:冠狀動脈內應用替囉非班在急性心肌梗死急診PCI中的臨床效果,明顯優于靜脈內應用替囉非班,建議在臨床上推廣應用。
목적::탐토관상동맥내응용체라비반재급성심기경사급진경피관상동맥개입치료( Percutaneous Coronary Interven-tion,PCI)중적림상효과。방법:수집2012년11월~2014년5월우본원치료적급성심기경사적75례환자위연구대상,장기수궤분위관찰조39례화대조조36례,관찰조여PCI후관상동맥내응용체라비반치료,대조조여PCI후정맥내응용체라비반치료,연후대2조환자술후심기재관주지표、술후1주심공능지표、술후1개월내심장불량사건진행통계급비교。결과:대비2조술후심기재관주지표、심장불량사건,균P<0.05,존재통계학차이,술후1주심공능지표P>0.05,무통계학의의。결론:관상동맥내응용체라비반재급성심기경사급진PCI중적림상효과,명현우우정맥내응용체라비반,건의재림상상추엄응용。
Objective:To investigate clinical effect of the intracoronary application for tirofiban in acute myocardial infarction after percutaneous coronary intervention (PCI). Method: from 2012 November ~2014 year in May,75 cases were collected in the hospital treatment of acute myocardial infarction patients as the research object, then they were randomly divided into observation group of 39 cases and 36 cases in the control group, the observation group for tirofiban treatment with PCI after intracoronary application, control group was given PCI after intravenous application of tirofiban treatment, and 2 groups of patients after myocardial reperfusion index, 1 weeks after the operation, heart function index, after 1 months of statistics and adverse cardiac events. Results:the two groups were compared after mark-er of myocardial reperfusion, cardiac adverse events, all P<0. 05, there was significant difference, 1 weeks after the operation, heart function indexes of P>0. 05, no statistical significance. Conclusion:in the clinical effect,the application of tirofiban in acute myocardial infarction of PCI in the coronary artery, is obviously better than that of intravenous application for tirofiban, recommended in clinical ap-plication.